Akshay Sood to Early Detection of Cancer
This is a "connection" page, showing publications Akshay Sood has written about Early Detection of Cancer.
Connection Strength
1.250
-
Bertini A, Cirulli GO, Stephens A, Finocchiaro A, Vigan? S, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Salonia A, Briganti A, Montorsi F, Sood A, Rogers C, Abdollah F. Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency. BJU Int. 2025 Nov; 136(5):818-825.
Score: 0.173
-
Cirulli GO, Stephens A, Chiarelli G, Finati M, Bertini A, Chase M, Tinsley S, Arora S, Sood A, Lughezzani G, Buffi N, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer Diagnosis: Analysis of a Contemporary North American Cohort. Prostate. 2025 May; 85(6):531-540.
Score: 0.167
-
Stephens A, Morrison C, Lutchka J, Richard C, Hares K, Tinsley S, Sood A, Shannon B, Rogers C, Shill J, Shakir N, Abdollah F. Prostate Cancer Screening and Diagnoses in the Transfeminine Population. Urology. 2025 03; 197:80-87.
Score: 0.165
-
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Corsi N, Williams E, Affas R, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis. J Urol. 2024 Oct; 212(4):560-570.
Score: 0.161
-
Vetterlein MW, Dalela D, Sammon JD, Karabon P, Sood A, Jindal T, Meyer CP, L?ppenberg B, Sun M, Trinh QD, Menon M, Abdollah F. State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update. Urology. 2018 Feb; 112:56-65.
Score: 0.101
-
Vetterlein MW, L?ppenberg B, Karabon P, Dalela D, Jindal T, Sood A, Chun FK, Trinh QD, Menon M, Abdollah F. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017 Sep 01; 123(17):3241-3252.
Score: 0.097
-
Jindal T, Kachroo N, Sammon J, Dalela D, Sood A, Vetterlein MW, Karabon P, Jeong W, Menon M, Trinh QD, Abdollah F. Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses. Urol Oncol. 2017 07; 35(7):460.e9-460.e20.
Score: 0.096
-
Sammon JD, Dalela D, Abdollah F, Choueiri TK, Han PK, Hansen M, Nguyen PL, Sood A, Menon M, Trinh QD. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era. J Urol. 2016 04; 195(4 Pt 1):913-8.
Score: 0.088
-
Pucheril D, Dalela D, Sammon J, Sood A, Sun M, Trinh QD, Menon M, Abdollah F. The influence of physician recommendation on prostate-specific antigen screening. Urol Oncol. 2015 Oct; 33(10):424.e1-7.
Score: 0.086
-
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Chase M, Tinsley S, Arora S, Sood A, Lughezzani G, Buffi N, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality. Cancer. 2025 Jan 01; 131(1):e35563.
Score: 0.041
-
Dalela D, Corsi NJ, Bronkema C, Sood A, Arora S, Majdalany SE, Butaney M, Jamil M, Li P, Palma-Zamora I, Rakic N, Kovacevic N, Jeong W, Menon M, Rogers CG, Schonberg MA, Abdollah F. Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making. Clin Genitourin Cancer. 2024 04; 22(2):269-280.e2.
Score: 0.038
-
Dalela D, Malchow T, Butaney M, Majdalany S, Corsi NJ, Rakic I, Sood A, Rogers C, Abdollah F. Temporal and Racial Trends in Prostate-specific Antigen Screening for U.S. Men With a Family History of Prostate Cancer. Urol Pract. 2023 09; 10(5):484-492.
Score: 0.037